| AI-based pathology predicts origins for cancers of unknown primary MY Lu, TY Chen, DFK Williamson, M Zhao, M Shady, J Lipkova, ... Nature 594 (7861), 106-110, 2021 | 406 | 2021 |
| Deep learning-based computational pathology predicts origins for cancers of unknown primary MY Lu, M Zhao, M Shady, J Lipkova, TY Chen, DFK Williamson, ... arXiv preprint arXiv:2006.13932, 2020 | 406* | 2020 |
| A rectal cancer organoid platform to study individual responses to chemoradiation K Ganesh, C Wu, KP O’Rourke, BC Szeglin, Y Zheng, CEG Sauvé, ... Nature medicine 25 (10), 1607-1614, 2019 | 367 | 2019 |
| Pan-cancer integrative histology-genomic analysis via multimodal deep learning RJ Chen, MY Lu, DFK Williamson, TY Chen, J Lipkova, Z Noor, M Shaban, ... Cancer Cell 40 (8), 865-878. e6, 2022 | 161 | 2022 |
| Multimodal co-attention transformer for survival prediction in gigapixel whole slide images RJ Chen, MY Lu, WH Weng, TY Chen, DFK Williamson, T Manz, M Shady, ... Proceedings of the IEEE/CVF International Conference on Computer Vision …, 2021 | 160 | 2021 |
| Multicenter prospective phase II trial of neoadjuvant dose-dense gemcitabine plus cisplatin in patients with muscle-invasive bladder cancer G Iyer, AV Balar, MI Milowsky, BH Bochner, G Dalbagni, SM Donat, ... Journal of clinical oncology 36 (19), 1949, 2018 | 123 | 2018 |
| Development of genome-derived tumor type prediction to inform clinical cancer care A Penson, N Camacho, Y Zheng, AM Varghese, H Al-Ahmadie, P Razavi, ... JAMA oncology 6 (1), 84-91, 2020 | 83 | 2020 |
| Deep learning-enabled assessment of cardiac allograft rejection from endomyocardial biopsies J Lipkova, TY Chen, MY Lu, RJ Chen, M Shady, M Williams, J Wang, ... Nature medicine 28 (3), 575-582, 2022 | 57 | 2022 |
| Evaluation of mode collapse in generative adversarial networks S Lala, M Shady, A Belyaeva, M Liu High Performance Extreme Computing, 2018 | 39 | 2018 |
| Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients DWY Tsui, ML Cheng, M Shady, JL Yang, D Stephens, H Won, ... Genome medicine 13 (1), 1-15, 2021 | 28 | 2021 |
| Comparison of somatic mutation profiles from cell free DNA (cfDNA) versus tissue in metastatic urothelial carcinoma (mUC). ML Cheng, M Shady, CK Cipolla, S Funt, ME Arcila, H Al-Ahmadie, ... Journal of Clinical Oncology 35 (15_suppl), 4533-4533, 2017 | 4 | 2017 |
| A rectal cancer model establishes a platform to study individual responses to chemoradiation K Ganesh, C Wu, KP O’Rourke, M Adileh, BC Szeglin, I Wasserman, ... bioRxiv, 640193, 2019 | 2 | 2019 |
| International Evaluation of Weakly-Supervised Ai-Model for Cardiac Allograft Rejection Screening J Lipkova, TY Chen, MY Lu, M Shady, M Williams, J Wang, RN Mitchell, ... Journal of the American College of Cardiology 77 (18_Supplement_1), 520-520, 2021 | 1 | 2021 |
| Abstract PO-002: Pan-cancer integrative histology-genomic analysis via interpretable multimodal deep learning RJ Chen, MY Lu, M Shady, J Lipkova, T Chen, DF Williamson, B Joo, ... Clinical Cancer Research 27 (5_Supplement), PO-002-PO-002, 2021 | 1 | 2021 |
| Genomic comparison of matched primary and metastatic germ cell tumors (GCT). F Audenet, M Donoghue, EJ Pietzak, S Isharwal, ML Cheng, G Iyer, ... Journal of Clinical Oncology 35 (15_suppl), 4556-4556, 2017 | 1 | 2017 |
| Identifying prognostic biomarkers for cancer using gene expression data M Shady Massachusetts Institute of Technology, 2019 | | 2019 |
| Abstract LB-227: Estimation of tumor-derived mutant allele fractions in cfDNA by shallow whole genome sequencing and fragment size analysis J Yang, F Marass, P Ulz, M Shady, ML Cheng, P Kothari, E Gedvilaite, ... Cancer Research 78 (13_Supplement), LB-227-LB-227, 2018 | | 2018 |
| Development and optimization of a comprehensive high-sensitivity NGS cancer assay and bioinformatics pipeline for plasma cfDNA profiling J Patel, M Hasan, F Meng, X Jing, D Perera, J Reichel, E Gedvilaite, ... Cancer Research 78 (13_Supplement), 5598-5598, 2018 | | 2018 |
| Estimation of tumor-derived mutant allele fractions in cfDNA by shallow whole genome sequencing and fragment size analysis J Yang, F Marass, P Ulz, M Shady, ML Cheng, P Kothari, E Gedvilaite, ... CANCER RESEARCH 78 (13), 2018 | | 2018 |
| OA 10.05 Non-Invasive Molecular Profiling in NSCLC by Targeted and Whole Exome Analysis of Plasma cfDNA M Cheng, J Yang, M Shady, P Ulz, E Heitzer, N Socci, V Seshan, M Offin, ... Journal of Thoracic Oncology 12 (11), S1772, 2017 | | 2017 |
